Skip to Main Content
  • About Us
  • People
  • Capabilities
  • News & Insights
  • Events
  1. Insights
  2. Publications

Not a Food, but Not Yet a Drug: Dietary Supplement Litigation and the Role of FDA

DRI

November 2019

Lawyers

Sarah A. Westby

Partner

860.251.5503

swestby@goodwin.com

Sarah Westby co-authored the DRI article "Not a Food, but Not Yet a Drug: Dietary Supplement Litigation and the Role of FDA." 

To read the full article, please click here.

Attachments

  • Printable PDF

Related Practices

  • Litigation

Related Industries

  • Cannabis
  • Food and Beverage

Keep in Touch

Stay current with our latest insights

Manage Subscriptions
  • Lawyers
  • Capabilities
  • Events
  • Diversity, Equity and Inclusion
  • Pro Bono and Community
  • Blogs and Resource Centers
  • Insights
  • Podcasts
  • Dobbs Decision Resource Center
  • About Us
  • Careers
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Accessibility Statement

© Shipman & Goodwin LLP 2025. All Rights Reserved